APTALIS PHARMA INC Revenue
APTALIS PHARMA INC reported Revenue of $152.40 million for the 3-month period ending 2011-12-31, per its 10-Q filed 2012-02-10.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2012-02-10
- APTALIS PHARMA INC revenues for the quarter ending 2011-12-31 was $152.40M, a 77.34% increase year-over-year.
- APTALIS PHARMA INC revenues for the quarter ending 2011-09-30 was $141.93M, a 103.89% increase year-over-year.
- APTALIS PHARMA INC revenues for the quarter ending 2011-06-30 was $131.16M, a 62.97% increase year-over-year.
- APTALIS PHARMA INC revenues for the quarter ending 2010-12-31 was $85.94M.
- APTALIS PHARMA INC revenues for fiscal 2011 was $470.38M, a 32.66% increase from fiscal 2010.
- APTALIS PHARMA INC revenues for fiscal 2010 was $354.59M, a 14.95% decline from fiscal 2009.
- APTALIS PHARMA INC revenues for fiscal 2009 was $416.94M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2011-12-31 | $152.40M 10-Q · filed 2012-02-10 | $294.33M derived: sum of 2 quarters · filed 2012-02-10 | $425.49M derived: sum of 3 quarters · filed 2012-02-10 | |
| 2011-09-30 | $141.93M derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | $273.09M derived: sum of 2 quarters · filed 2011-12-20 | $470.38M 10-K · filed 2011-12-20 | |
| 2011-06-30 | $131.16M 10-Q · filed 2011-08-12 | $328.45M 10-Q · filed 2011-08-12 | ||
| 2010-12-31 | $85.94M 10-Q · filed 2012-02-10 | $155.55M derived: sum of 2 quarters · filed 2012-02-10 | $236.03M derived: sum of 3 quarters · filed 2012-02-10 | |
| 2010-09-30 | $69.61M derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | $150.09M derived: sum of 2 quarters · filed 2011-12-20 | $354.59M 10-K · filed 2011-12-20 | |
| 2010-06-30 | $80.48M 10-Q · filed 2011-08-12 | $284.98M 10-Q · filed 2011-08-12 | ||
| 2009-09-30 | $416.94M 10-K · filed 2011-12-20 |